The stock's fall snapped a two-day winning streak.

Citi analyst Joanne Wuensch maintained a Buy rating on Dexcom (DXCM – Research Report) today. The company’s shares closed yesterday at ...

DexCom (DXCM) announced the FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for people over the age of 18 with ...

Shares of DexCom Inc. DXCM shed 9.30% to $61.80 Thursday, on what proved to be an all-around grim trading session for the ...

Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...

Dexcom is preparing to launch a 15-day version of its G7 continuous glucose monitor, based on data presented Thursday at the Advanced Technologies & Treatments for Diabetes conference. Dexcom pointed ...

Here are three highlights from the first day of the conference: 1. Dexcom previews new data for 15-day glucose monitor Dexcom shared the first data for its 15-day continuous glucose monitor ahead of a ...

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes to ...

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "Diabetic Care Devices Market" report has been added to ResearchAndMarkets.com's offering. The Diabetic Care Devices Market was valued at USD 16.6 ...

DexCom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing, today announced the launch of its first multi-region report, the "Dexcom State of Type 2 Report: Access and Attitudes Across ...

At the conference, first-ever accuracy and performance data will be presented for Dexcom’s upcoming G7 15 Day system, 1 showing an overall mean absolute relative difference (MARD) of 8.0% ...